Rapport Therapeutics, Inc. ($RAPP)
Filing Information
| Accession Number | 0001193125-26-368244 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 26, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
50,160
Total Value
$2,531,582.37
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer | Common Stock | โ | Aug 24, 2026 | Sale | 13,160 | $50.00 | $657,977.63 | 232,862 | Direct | โ | View Details | |
Chief Development Officer | Common Stock | โ | Aug 25, 2026 | Sale | 20,799 | $50.31 | $1,046,420.57 | 212,063 | Direct | โ | View Details | |
Chief Development Officer | Common Stock | โ | Aug 25, 2026 | Sale | 16,201 | $51.06 | $827,184.18 | 195,862 | Direct | โ | View Details |